Type 2 Diabetes Trial, Recruiting NCT06337812 Sponsor: University of Michigan Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06337812
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of stable heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is too stiff), and whose heart failure medications have not changed in the past month
  • People whose heart has been shown in the past 12 months to pump out more than 50% of its blood with each beat (a measure of heart function)
  • People who have a confirmed diagnosis of Type 2 diabetes with a blood sugar control reading (HbA1c) below 10%, and whose diabetes medications have not changed in the past month

Who may not be able to join:

  • People who are currently taking pre- or probiotic supplements
  • People who have taken antibiotics in the past 6 months
  • People who are currently taking part in another clinical trial that involves a treatment or intervention
  • People who have a history of allergy to potato or potato starch, or who have irritable bowel syndrome, inflammatory bowel disease, bowel resection surgery, Roux-en-Y gastric bypass surgery, coeliac disease, Crohn's disease, or colorectal cancer
  • People who have had a low blood sugar episode in the past month
  • People who have advanced chronic kidney disease (stage 4 or 5)
  • People who are pregnant (based on self-report)
  • People who have another serious illness that is expected to limit survival to less than 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Scott Hummel, MD, MS, University of Michigan

Phone: 734-726-0308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in Short Chain Fatty Acid (SCFA) butyrate levels - stool; Changes in Short Chain Fatty Acid (SCFA) butyrate levels - plasma; Changes in propionate levels - stool; Changes in propionate levels- plasma; Changes in acetate levels- stool; Changes in acetate levels- plasma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov